Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern A Matas-García, JC Milisenda, A Selva-O'Callaghan, S Prieto-González, ... Autoimmunity Reviews 19 (2), 102455, 2020 | 54 | 2020 |
Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy LM Rodas, A Matas-García, X Barros, M Blasco, O Vinas, A Llobell, ... Clinical Kidney Journal 12 (1), 36-41, 2019 | 34 | 2019 |
Beta‐2‐Glycoprotein‐I Deficiency Could Precipitate an Antiphospholipid Syndrome‐like Prothrombotic Situation in Patients With Coronavirus Disease 2019 M Serrano, G Espinosa, A Lalueza, LY Bravo‐Gallego, R Diaz‐Simón, ... ACR Open Rheumatology 3 (4), 267-276, 2021 | 25 | 2021 |
Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis I Pinal-Fernandez, A Quintana, JC Milisenda, M Casal-Dominguez, ... Annals of the rheumatic diseases 82 (6), 829-836, 2023 | 15 | 2023 |
Clinico–pathological phenotypes of systemic sclerosis–associated myopathy: analysis of a large multicentre cohort A Matas-García, A Guillén-Del-Castillo, B Kisluk, A Selva-O'Callaghan, ... Rheumatology 62 (SI), SI82-SI90, 2023 | 12 | 2023 |
Persistent antiphospholipid antibodies are not associated with worse clinical outcomes in a prospective cohort of hospitalised patients with SARS-CoV-2 infection G Espinosa, C Zamora-Martínez, A Pérez-Isidro, D Neto, ... Frontiers in Immunology 13, 911979, 2022 | 9 | 2022 |
Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study E Fonseca, JM Cabrera-Maqueda, R Ruiz-García, L Naranjo, ... The Lancet Neurology 22 (12), 1150-1159, 2023 | 8 | 2023 |
Gastrointestinal involvement in dermatomyositis A Matas-Garcia, JC Milisenda, G Espinosa, M Cuatrecasas, ... Diagnostics 12 (5), 1200, 2022 | 8 | 2022 |
Anoctamin 5 (ANO5) muscular dystrophy—three different phenotypes and a new histological pattern F Seguí, L Gonzalez-Quereda, A Sanchez, A Matas-García, G Garrabou, ... Neurological Sciences 41, 2967-2971, 2020 | 8 | 2020 |
An analysis based on sex&gender in the chest pain unit of an emergency department during the last 12 years G Martinez-Nadal, O Miro, A Matas, P Cepas, A Aldea, M Izquierdo, ... European Heart Journal Acute Cardiovascular Care 10 (Supplement_1), zuab020. 122, 2021 | 7 | 2021 |
Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies I Pinal-Fernandez, JC Milisenda, K Pak, S Muñoz-Braceras, ... Annals of the rheumatic diseases 82 (8), 1091-1097, 2023 | 3 | 2023 |
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature NL Guerra, A Matas-García, L Serra-García, D Morgado-Carrasco, ... Autoimmunity Reviews, 103375, 2023 | 3 | 2023 |
Time intervals in the pathway to emergency cancer diagnosis X Bosch, E Montori-Palacin, J Naval-Álvarez, A Matas, P Moreno, ... Future Oncology 19 (12), 829-843, 2023 | 2 | 2023 |
Systemic sclerosis-associated myopathy: How to treat A Selva-O’Callaghan, A Guillen-Del-Castillo, A Gil-Vila, ... Current Treatment Options in Rheumatology 9 (4), 151-167, 2023 | 1 | 2023 |
HEMOCOVID-19 study: An international clinical study to evaluate microvascular and endothelial impairments in severe COVID-19 patients using near-infrared spectroscopy L Cortese, LB de Oliveira, M Barcelona, LEB Delazari, B Besen, ... European Conference on Biomedical Optics, ETh3A. 1, 2021 | 1 | 2021 |
Specific sex and gender factors of pericarditis in women PL Cepas Guillen, G Martinez-Nadal, M Izquierdo, A Aldea, A Matas, ... European Heart Journal 41 (Supplement_2), ehaa946. 3176, 2020 | 1 | 2020 |
Clinical features of pericarditis with and without myocardial involvement diagnosed in the emergency department and factors associated with need for hospitalization G Martínez-Nadal, A Prepoudis, Ò Miró, A Matas, P Cepas, A Aldea, ... Emergencias 32, 97-104, 2020 | 1 | 2020 |
Características clínicas de las pericarditis y miopericarditis diagnosticadas en urgencias y factores asociados con la necesidad de hospitalización GM Nadal, A Prepoudis, ÓM Andreu, A Matas, P Cepas, AA Parés, ... Emergencias: Revista de la Sociedad Española de Medicina de Urgencias y …, 2020 | 1 | 2020 |
Pathogenic autoantibody internalization in myositis I Pinal-Fernandez, S Munoz-Braceras, M Casal-Dominguez, K Pak, ... medRxiv, 2024.01. 15.24301339, 2024 | | 2024 |
Treatment of Myositis Associated With Immune Checkpoint Inhibitors A Matas-García, E Martinez-Hernandez, JC Milisenda Current Treatment Options in Rheumatology 9 (4), 179-191, 2023 | | 2023 |